Robert Wood Johnson University Hospital
Locations
Transplant Summary
Overview
In collaboration with Robert Wood Johnson University Hospital, a RWJBarnabas Health facility, the Adult Transplant and Cellular Therapy Program at Rutgers Cancer Institute performs autologous, allogeneic, matched, mismatched, haploidentical and cord blood transplants and immune effector cell therapy.
The Pediatric Transplant and Cellular Therapy Program at Rutgers Cancer Institute and The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital offers children, adolescents, and young adults stem cell transplantation for cancer and blood disorders as well as gene therapy and immune effector cell therapy.
Rutgers Cancer Institute is the only program in New Jersey offering these therapies at an NCI-designated Comprehensive Cancer Center.This center has been performing allogeneic transplants since 2002 and has been an NMDP transplant center since July 2005.
Attending physicians
Adult - Ira Braunschweig, Ogechukwu Egini, Adrienne Phillips, Emma Rabinovich, Emma Rabinovich, Dale Schaar, Niketa ShahTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult onlyOther programs and services
The Embrace Kids Foundation in affiliation with Rutgers Cancer institute and Robert Wood Johnson University Hospital has a mission to lighten the burden, maintain normalcy and improve quality of life for families whose children are facing cancer, sickle cell and other serious health challenges. The Embrace Kids Foundation funds numerous programs and services including the Children’s School Program, which is a fully accredited, state-certified learning center.
The Ronald McDonald House in New Brunswick is located adjacent to the Robert Wood Johnson University campus.
We have a partnership with several local hotels for discounted rates for patients and their caregivers.
Patients are provided with social work, mental health, chaplaincy support throughout the process.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 113 patients.The actual 1-year survival of these patients is 77.9%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 70.5% and 85.3%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
337
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow1PBSC31Cord blood0Total32Unrelated donorMarrow2PBSC47Cord blood2Total51Total allogeneicMarrow3PBSC78Cord blood2Total83AutologousMarrowBoth marrow & PBSC 254PBSC—Cord blood—Total254Total combinedMarrowBoth marrow & PBSC 335PBSC—Cord blood2Total337All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-44745-641965+6Total32Unrelated 0-18019-441445-642465+13Total51Autologous 0-18019-445245-6413165+71Total254Total 0-18019-447345-6417465+90Total337Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Robert Wood Johnson University Hospital/Rutgers Cancer Instiute of New Jersey
1 RWJ Place New Brunswick, NJ 8901 Phone:732-235-2465 Physician Referrals:732-235-8515 Overview
This comprehensive program follows adult post-transplant recipients over the age of 18 beginning at 1 year. Each patient within the program is given a long-term follow-up survivorship care plan which encompasses the following surveillance: immune function, skin, eyes, mouth, lungs, muscles/fascia, GI tract, liver, genitalia. Patients will be evaluated for long-term complications- especially Chronic GVHD. Patients will have access to specialty physicians who help manage post-transplant long-term issues along with our medical team. Our long-term post-transplant survivorship program encompasses cutting edge care with the support of nurse navigators, social work, financial counselors, dieticians, and psychiatry support.
Staff
Program Director:Ira Braunschweig, NGProgram Coordinator:Jacqueline Manago, RNMedical Specialties in Program
Dermatology, gastroenterology, gynecology, hematology, infectious disease, nephrology, oncology, psychiatry/psychology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, nutrition/dietetics, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic transplant recipients
- Adults: 1 year after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital